Kadima Neuropsychiatry Institute, founded in 2017, is a leading mental health clinic based in San Diego, specializing in innovative treatments including Transcranial Magnetic Stimulation (TMS) Therapy, Ketamine Therapy, Psychedelic Assisted Therapy, and Spravato. The institute is dedicated to providing advanced solutions for conditions such as depression, anxiety, PTSD, and OCD when traditional treatments prove ineffective. Additionally, it conducts clinical research trials, offering patients access to investigational treatments, including psychedelics, not available elsewhere. With a slogan that emphasizes using innovation and compassion to help patients progress towards a more fulfilling life, Kadima Neuropsychiatry Institute focuses on Health Care and Health and Wellness industries. Overall, it has positioned itself as a go-to choice for individuals seeking cutting-edge mental health treatments.
There is no investment information
No recent news or press coverage available for Kadima Neuropsychiatry Institute.